期刊文献+

基于层次分析法的用药合理性分析 被引量:5

Rationality Analysis on Medication Based on AHP
暂未订购
导出
摘要 目的:通过对某县人民医院2009年门诊处方用药的合理性分析,以了解该院门诊患者处方用药的基本情况。方法:运用层次分析法,对处方药用药情况进行考察,并结合临床实际,对处方用药的合理性进行分析评价。结论:该院门诊用药基本合理,但仍存在一定问题,同时临床医师与药师应共同加强药学知识的学习,临床医师应加强合理用药,药师应加强处方审核。 Objective:To make the rationality analysis on the prescription medication of a county-level hospital in 2009 to obtain the basic information about out-patients’prescription medication.Method: Adopting AHP to study the situation of the use of prescription medicines,and combined with the clinical practice,to analyze and evaluate the rationality of prescription medication.Conclusion: The clinical medication of this hospital is basically rational,but some problem still exist,the clinicians and pharmacists should strengthen the learning of pharmaceutical knowledge,the clinicians should strengthen rational drug use,and the pharmacists should strengthen the prescription audit.
作者 陈晓凤
机构地区 山西财经大学
出处 《科技情报开发与经济》 2010年第31期165-167,176,共4页 Sci-Tech Information Development & Economy
关键词 层次分析法 用药合理性分析 处方用药 AHP rationality analysis on medication prescription medication
  • 相关文献

参考文献2

二级参考文献19

共引文献13

同被引文献34

  • 1唐元义,胡清峰,骆有德.层次分析法的一种新标度法[J].鄂州大学学报,2005,12(6):40-41. 被引量:17
  • 2潘广锋,徐静.层次分析法在企业物流模式选择中的应用[J].山东交通学院学报,2005,13(4):36-39. 被引量:8
  • 3刘立存,周凌云.层次分析法在物流信息系统开发模式决策中的应用[J].交通运输工程与信息学报,2006,4(2):76-81. 被引量:2
  • 4武志昂.全国药品不良反应监测中心主任工作会议工作报告[J].中国药物警戒,2007,4(4):194-199. 被引量:16
  • 5Plehn J F,Davis B R,Sacks F M,et al.Reduction of stroke incidence after myocardial infarction with pravastatin:the Cholesterol and Recurrent Events(CARE)study.The Care Investigators.Circulation,1999,9(9):216-223.
  • 6Law MR,Wald NJ,Rudnicka AR.Quantifying effect of statins on low density lipoprotein cholesterol,ischaemic heart disease,and stroke:systematic review and meta-analysis.BMJ.2003,326(7404):1423-1427.
  • 7Scott M.Grundy,James I.Cleeman,C.Noel Bairey Merz,et al.Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines.Circulation.2004,110(2):227-239.
  • 8LaRosa JC,Grundy SM,Waters DD.Intensive lipid lowering withatorvastatin in patients with stable coronary disease.N Engl J Med,2005,352(14):1425-1435.
  • 9Baigent C,Keech A,Kearney PM.Efficacy and safety of cholesterol lowering treatment:prospective meta analysis of data from 90,056 participants in 14 randomised trials of statins.Lancet,2005,366(9493):1267-1278.
  • 10陈新谦,金有豫,汤光.新编药物学.16版.北京:人民卫生出版社,2003:664-697.

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部